Clearbridge Investments, LLC Novartis Ag Transaction History

Clearbridge Investments, LLC

$127 Billion
Q3 2025

A detailed history of Clearbridge Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,101 shares of NVS stock, worth $276,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,101

Previous 2,351 10.63%

Holding current value

$276,386

Previous $284,000 5.28%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$113.5 - $129.73 $28,375 - $32,432	-250 Reduced 10.63%	2,101 $269,000
Q2 2024 Aug 27, 2024	BUY	$92.57 - $107.37 $217,632 - $252,426	2,351 New	2,351 $250,000
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $23,341 - $26,575	-245 Reduced 9.44%	2,351 $227,000
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $94,207 - $103,672	-1,021 Reduced 28.23%	2,596 $262,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $61,100 - $67,808	645 Added 21.7%	3,617 $368,000

Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $462 - $524	-5 Reduced 0.17%	2,972 $299,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $880 - $1,020	-11 Reduced 0.37%	2,977 $273,000
Q4 2022 Feb 10, 2023	BUY	$75.55 - $92.52 $7,403 - $9,066	98 Added 3.39%	2,988 $271,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $383,719 - $448,778	-5,143 Reduced 64.02%	2,890 $220,000
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $23,511 - $27,375	-292 Reduced 3.51%	8,033 $679,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $2.48 Million - $2.81 Million	-30,990 Reduced 78.82%	8,325 $731,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $117,637 - $130,079	-1,476 Reduced 3.62%	39,315 $3.44 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $452,079 - $525,933	5,528 Added 15.68%	40,791 $3.34 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $200,825 - $221,817	-2,356 Reduced 6.26%	35,263 $3.22 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $129 Million - $152 Million	-1,539,513 Reduced 97.61%	37,619 $3.22 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $616,206 - $745,335	7,893 Added 0.5%	1,577,132 $149 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $25.9 Million - $28.6 Million	-314,736 Reduced 16.71%	1,569,239 $136 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $339,986 - $382,711	4,201 Added 0.22%	1,883,975 $165 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $10 Million - $14.1 Million	142,047 Added 8.17%	1,879,774 $155 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $14.5 Million - $16.4 Million	171,577 Added 10.96%	1,737,727 $165 Million
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $6.1 Million - $6.72 Million	71,344 Added 4.77%	1,566,150 $136 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $18 Million - $22.2 Million	239,378 Added 19.07%	1,494,806 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $32.5 Million - $37.1 Million	430,876 Added 52.26%	1,255,428 $121 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $3.11 Million - $3.46 Million	42,175 Added 5.39%	824,552 $70.8 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $4.82 Million - $5.57 Million	71,953 Added 10.13%	782,377 $67.4 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $284,630 - $321,683	4,385 Added 0.62%	710,424 $53.7 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $4.84 Million - $5.79 Million	-68,779 Reduced 8.88%	706,039 $57.1 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $223,716 - $240,140	-3,093 Reduced 0.4%	774,818 $65.1 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $407,992 - $425,216	-5,503 Reduced 0.7%	777,911 $66.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	783,414	783,414 $65.4 Million

Others Institutions Holding NVS

# of Institutions

1,625

Shares Held

136M

Call Options Held

1.53M

Put Options Held

2.22M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $283B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Novartis Ag Transaction History